oxidopamine has been researched along with Tremor in 17 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to examine the influence of a unilateral 6-hydroxydopamine (6-OHDA)-induced partial lesion of both the substantia nigra pars compacta (SNc, A9) and retrorubral field (RRF, A8) on the tremor evoked by harmaline." | 7.78 | 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats. ( Berghauzen, K; Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Schulze, G, 2012) |
| "Abnormal synchronous activation of the glutamatergic olivo-cerebellar pathway has been suggested to be crucial for the harmaline-induced tremor." | 7.77 | Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats. ( Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Pastuszka, A, 2011) |
| "The effect of 6-hydroxydopamine on repeated nicotine-induced tail-tremor was investigated in rats." | 7.70 | Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats. ( Araki, H; Gomita, Y; Kawakami, Y; Suemaru, K; Tanizaki, Y, 1998) |
| "The effects of nicotinic and beta-adrenergic receptor antagonists on tail-tremor induced by repeated nicotine administration were investigated in rats." | 7.69 | Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. ( Gomita, Y; Kawasaki, H; Oishi, R; Suemaru, K; Tanizaki, Y, 1997) |
| "It has previously been reported that intracerebroventricular administration of neurotensin (30 micrograms) reduced muscular rigidity and tremors, induced by a neurochemical lesion with 6-hydroxydopamine in the posterolateral hypothalamus of rats." | 7.68 | Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat. ( Jolicoeur, FB; Rivest, R; St-Pierre, S, 1991) |
| " Intact male GPR88 KO mice showed diminished tacrine-induced PD-like tremor and spontaneous hyperlocomotion." | 3.96 | Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia. ( Mannoury-la-Cour, C; Mantas, I; Millan, MJ; Svenningsson, P; Yang, Y; Zhang, X, 2020) |
| "The aim of the present study was to examine the influence of a unilateral 6-hydroxydopamine (6-OHDA)-induced partial lesion of both the substantia nigra pars compacta (SNc, A9) and retrorubral field (RRF, A8) on the tremor evoked by harmaline." | 3.78 | 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats. ( Berghauzen, K; Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Schulze, G, 2012) |
| "Abnormal synchronous activation of the glutamatergic olivo-cerebellar pathway has been suggested to be crucial for the harmaline-induced tremor." | 3.77 | Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats. ( Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Pastuszka, A, 2011) |
| ") proved capable of reducing jaw tremors in tacrine model of Parkinson's disease tremor." | 3.74 | Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. ( Borsini, F; Carminati, P; Frau, L; Morelli, M; Schintu, N; Simola, N; Tronci, E, 2007) |
| " When an animal moves on the plate, its movements are sensed by the transducers whose signals are processed by computer to yield measurements of a wide range of behaviors or behavioral attributes, such as locomotor activity, rotation around the center, whole-body tremor, and amphetamine-induced stereotypies." | 3.71 | A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. ( Birkestrand, BR; Chen, R; Fowler, SC; Moss, SJ; Vorontsova, E; Wang, G; Zarcone, TJ, 2001) |
| "The effect of 6-hydroxydopamine on repeated nicotine-induced tail-tremor was investigated in rats." | 3.70 | Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats. ( Araki, H; Gomita, Y; Kawakami, Y; Suemaru, K; Tanizaki, Y, 1998) |
| " Because prenylated proteins are avid methyl acceptors at the terminal carboxylic acid groups, 1 micromol S-farnesylcysteine (FC) analogs blocked the SAM-induced tremors in the experimental rats." | 3.70 | Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. ( Charlton, CG; Lamango, NS, 2000) |
| "The effects of nicotinic and beta-adrenergic receptor antagonists on tail-tremor induced by repeated nicotine administration were investigated in rats." | 3.69 | Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. ( Gomita, Y; Kawasaki, H; Oishi, R; Suemaru, K; Tanizaki, Y, 1997) |
| "It has previously been reported that intracerebroventricular administration of neurotensin (30 micrograms) reduced muscular rigidity and tremors, induced by a neurochemical lesion with 6-hydroxydopamine in the posterolateral hypothalamus of rats." | 3.68 | Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat. ( Jolicoeur, FB; Rivest, R; St-Pierre, S, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Mantas, I | 1 |
| Yang, Y | 1 |
| Mannoury-la-Cour, C | 1 |
| Millan, MJ | 1 |
| Zhang, X | 1 |
| Svenningsson, P | 1 |
| Pinna, A | 1 |
| Bonaventura, J | 1 |
| Farré, D | 1 |
| Sánchez, M | 1 |
| Simola, N | 2 |
| Mallol, J | 1 |
| Lluís, C | 1 |
| Costa, G | 1 |
| Baqi, Y | 1 |
| Müller, CE | 1 |
| Cortés, A | 1 |
| McCormick, P | 1 |
| Canela, EI | 1 |
| Martínez-Pinilla, E | 1 |
| Lanciego, JL | 1 |
| Casadó, V | 1 |
| Armentero, MT | 1 |
| Franco, R | 1 |
| Mu, X | 1 |
| Yuan, X | 1 |
| Du, LD | 1 |
| He, GR | 1 |
| Du, GH | 1 |
| Kolasiewicz, W | 2 |
| Kuter, K | 2 |
| Nowak, P | 2 |
| Pastuszka, A | 1 |
| Ossowska, K | 2 |
| Bethel-Brown, CS | 1 |
| Morris, JK | 1 |
| Stanford, JA | 1 |
| Berghauzen, K | 1 |
| Schulze, G | 1 |
| Aubin, N | 1 |
| Barneoud, P | 1 |
| Carter, C | 1 |
| Caille, D | 1 |
| Sontag, N | 1 |
| Marc, C | 1 |
| Lolivier, J | 1 |
| Gardes, A | 1 |
| Perron, C | 1 |
| Le Kim, A | 1 |
| Charieras, T | 1 |
| Pandini, M | 1 |
| Burnier, P | 1 |
| Puech, F | 1 |
| Jegham, S | 1 |
| George, P | 1 |
| Scatton, B | 1 |
| Curet, O | 1 |
| Tronci, E | 1 |
| Borsini, F | 1 |
| Schintu, N | 1 |
| Frau, L | 1 |
| Carminati, P | 1 |
| Morelli, M | 1 |
| Suemaru, K | 2 |
| Kawasaki, H | 1 |
| Oishi, R | 1 |
| Gomita, Y | 2 |
| Tanizaki, Y | 2 |
| Kawakami, Y | 1 |
| Araki, H | 1 |
| Lindner, MD | 1 |
| Cain, CK | 1 |
| Plone, MA | 1 |
| Frydel, BR | 1 |
| Blaney, TJ | 1 |
| Emerich, DF | 1 |
| Hoane, MR | 1 |
| Fukuzaki, K | 1 |
| Kamenosono, T | 1 |
| Nagata, R | 1 |
| Lamango, NS | 1 |
| Charlton, CG | 1 |
| Fowler, SC | 1 |
| Birkestrand, BR | 1 |
| Chen, R | 1 |
| Moss, SJ | 1 |
| Vorontsova, E | 1 |
| Wang, G | 1 |
| Zarcone, TJ | 1 |
| Jolicoeur, FB | 2 |
| Rivest, R | 2 |
| Drumheller, A | 1 |
| St-Pierre, S | 1 |
| Buonamici, M | 1 |
| Maj, R | 1 |
| Pagani, F | 1 |
| Rossi, AC | 1 |
| Khazan, N | 1 |
17 other studies available for oxidopamine and Tremor
| Article | Year |
|---|---|
Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Corpus Striatum; Dopami | 2020 |
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Cannabinoid Receptor Antagonists; | 2014 |
Antagonism of quercetin against tremor induced by unilateral striatal lesion of 6-OHDA in rats.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Male; Molecular Structure; Neuroprote | 2016 |
Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.
Topics: Adrenergic Agents; Animals; Brain Chemistry; Central Nervous System Stimulants; Cerebellum; Chromato | 2011 |
Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease.
Topics: Adrenergic Agents; Aging; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Forelimb; Male | 2011 |
6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Central Nervous System Stimulants; Cereb | 2012 |
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Anim | 2004 |
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavi | 2007 |
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Carteolol; Dimethylphenylpiperazinium Iodid | 1997 |
Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats.
Topics: Animals; Brain; Brain Chemistry; Catecholamines; Drug Administration Schedule; Injections, Intraperi | 1998 |
Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Brain Mapping; Corpus Striatum; Dementia; Dopa | 1999 |
Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Catalepsy; Dopamine Agonists; Indoles; Macaca fascicul | 2000 |
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Chromatography, Gel; Cysteine; Freeze Dryin | 2000 |
A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor.
Topics: Amphetamine; Animals; Behavior, Animal; Biomechanical Phenomena; Central Nervous System; Dopamine Up | 2001 |
Hypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Dyskinesia, Drug-Induced; Homovanillic Aci | 1991 |
Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat.
Topics: Animals; Cerebral Ventricles; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxydopam | 1991 |
Tremor at rest episodes in unilaterally 6-OHDA-induced substantia nigra lesioned rats: EEG-EMG and behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Electroencephalography; Electromyography; Hydroxydopamines; | 1986 |